Prevalence of current tobacco use, males in Andorra
Andorra: Prevalence of current tobacco use, males was 34.6% in 2024. ▼ Falling
Prevalence of current tobacco use, males in Andorra, 2000–2024
Source: Global Health Observatory Data Repository, World Health Organization (WHO). Measured in % of male adults.
Analysis
The most recent figure for prevalence of current tobacco use, males in Andorra is 34.6%, measured in 2024. That is the lowest value across all 9 years on record.
The figure is down 0.9% on the previous year and down 7.7% over ten years.
Over the whole period, prevalence of current tobacco use, males in Andorra peaked at 43.3% in 2000 and was at its lowest, 34.6%, in 2024.
Andorra ranks 59th of 166 countries on this measure, in the middle of the range.
Prevalence of current tobacco use, males in Andorra, year by year
| Year | % of male adults | Change |
|---|---|---|
| 2000 | 43.3% | — |
| 2005 | 40.9% | -5.5% |
| 2007 | 40.6% | -0.7% |
| 2010 | 39.2% | -3.4% |
| 2015 | 37.5% | -4.3% |
| 2020 | 35.8% | -4.5% |
| 2022 | 35.0% | -2.2% |
| 2023 | 34.9% | -0.3% |
| 2024 | 34.6% | -0.9% |
Andorra compared with similar countries
- Andorra's 34.6% is above the median for high income countries, which is 25.9%, 1.3× the median. (57 countries reporting)
- Andorra's 34.6% is above the median for Europe & Central Asia, which is 34.4%, 1.0× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 41.6% | 40.6% | 43.3% | 3 |
| 2010s | 38.4% | 37.5% | 39.2% | 2 |
| 2020s | 35.1% | 34.6% | 35.8% | 4 |
Countries ranked near Andorra
More health data for Andorra
- Estimated changes in temperature-related death rates compared to projected death rates 1,824 deaths per 1,000 people (2090)
- Heat deaths vs projected death rates, annual growth rate 0.0878 % change on previous year (2090)
- Un projection of annual infant deaths, annual growth rate -100 % change on previous year (2077)
- Number of infants who die before age 1 0 deaths (2100)
- Age population, age 07, female, interpolated 296 (2025)
- Age population, age 09, male, interpolated 371 (2025)
- Age population, age 09, female, interpolated 345 (2025)
- Age population, age 08, male, interpolated 358 (2025)
- Age population, age 08, female, interpolated 329 (2025)
- Age population, age 07, male, interpolated 329 (2025)
Frequently asked questions
- What is prevalence of current tobacco use, males in Andorra?
- Prevalence of current tobacco use, males in Andorra was 34.6% in 2024, according to Global Health Observatory Data Repository, World Health Organization (WHO).
- What is the highest prevalence of current tobacco use, males recorded in Andorra?
- The highest recorded value was 43.3% in 2000.
- What is the lowest prevalence of current tobacco use, males recorded in Andorra?
- The lowest recorded value was 34.6% in 2024.
- How does Andorra rank for prevalence of current tobacco use, males?
- Andorra ranks 59th out of 166 countries with data for 2024.
- Is prevalence of current tobacco use, males rising or falling in Andorra?
- Over the last ten years it is down 7.7%. The long-run trend across the full record is falling.
- Where does this Andorra data come from?
- The figures come from Global Health Observatory Data Repository, World Health Organization (WHO), published as part of Prevalence of current tobacco use, males (% of male adults). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 9 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of the male population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.